Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Biotech Stocks to Buy in April

TheMotleyFool

0 0

Biotech stocks, in general, again performed dismally in the first quarter of 2022. However, there are some signs of improvement. The lower valuations could present a great buying opportunity once the inevitable strong rebound materializes.

We asked three Motley Fool contributors which biotech stocks they think are good picks to buy in April. Here's why they chose Amgen (NASDAQ: AMGN), Jazz Pharmaceuticals (NASDAQ: JAZZ), and Novocure (NASDAQ: NVCR).

Image source: Getty Images.

Source Fool.com

Like: 0

AMGN

Share